bempegaldesleukin,nivolumab
bms,nektar
['rcc,(-irccs),(-srcc),(-urcc)', 'biomarker', 'pivot,9']
proud of how #nizartannir dealt with pivot09 data today at #esmo22 we need biomarkers to identify which rcc pts are benefiting more from immunotherapy 
Jefe del Servicio de #Oncología Médica y Director de Investigación Clínica de la Fundación MD Anderson Cancer Center Madrid. Opinions are my own